Fischer Medical Ventures Limited has announced the reconstitution of its Board of Directors' committees, effective January 1, 2026. This decision was approved via a circular resolution passed on January 1, 2026, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Audit Committee will be chaired by Mr. Khairy Jamaluddin Abu Bakar, with members including Mr. Sanjay Jayantilal Jain, Mr. Roberto Mamangon Pagdanganan, Ms. Jaya Ankur Singhania, Mr. Ravindran Govindan, Dr. Syed Jalaludin, and Mr. Chan Sing En. The Nomination and Remuneration Committee will also be chaired by Mr. Khairy Jamaluddin Abu Bakar. Its members are Mr. Roberto Mamangon Pagdanganan, Ms. Jaya Ankur Singhania, Mr. Ravindran Govindan, and Dr. Syed Jalaludin. The Risk Management Committee will be chaired by Ms. Svetlana Rao Raviwada. The committee members include Mr. Khairy Jamaluddin Abu Bakar, Mr. Ravindran Govindan, Ms. Jaya Ankur Singhania, Mr. Chan Sing En, Mr. Shankar Varadharajan, and Mr. Vivek Balasubramanian. Furthermore, the Corporate Social Responsibility Committee will be chaired by Ms. Svetlana Rao Raviwada, with Mr. Roberto Mamangon Pagdanganan, Ms. Jaya Ankur Singhania, Mr. Ravindran Govindan, and Mr. Chan Sing En serving as members.
